Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.
Journal: JCO precision oncology
Published: July 10, 2026
Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 02, 2026
Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].
Journal: Gynecologic oncology
Published: June 02, 2026
An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
Journal: Expert review of anticancer therapy
Published: April 30, 2026
Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 28, 2026
Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 28, 2026
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.
Journal: Gynecologic oncology
Published: March 24, 2026
Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trials.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 16, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
Journal: Lancet (London, England)
Published: February 10, 2026
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 04, 2026
Mirvetuximab soravtansine and low-grade serous ovarian cancer: innovation awaiting validation.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 22, 2025
Last Updated: 09/26/2026